| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | Sep 11, 2025 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 3.8 | -18,000 | -95.87% | ✓ | $8.4M |
| Aug 29, 2024 | May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. | Director | Buy | 90.0 | +775 | 100.00% | ✗ | $2K |
| Sep 3, 2024 | Sep 4, 2024 | MYRIAD GENETICS INC | Director | Sell | 5.0 | -46,012 | -51.96% | ✓ | $1.3M |